125 related articles for article (PubMed ID: 3356924)
1. Recurrent sulfonylurea induced nocturnal hypoglycemia managed with tolbutamide.
Borst GC
J Ky Med Assoc; 1988 Mar; 86(3):129-30. PubMed ID: 3356924
[No Abstract] [Full Text] [Related]
2. Predictors of relapse in elderly diabetic patients admitted with sulphonylurea-induced severe hypoglycaemic attacks.
Chan TY; Cheung AY
Age Ageing; 1997 Sep; 26(5):409-10. PubMed ID: 9351488
[No Abstract] [Full Text] [Related]
3. [Role of octreotide in the treatment of hypoglycemia induced by sulfonylureas].
Clerc D; Hugli O; Trueb L; Yersin B
Rev Med Suisse; 2008 Aug; 4(167):1764-7. PubMed ID: 18800755
[TBL] [Abstract][Full Text] [Related]
4. Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.
Holstein A; Hammer C; Hahn M; Kulamadayil NS; Kovacs P
Expert Opin Drug Saf; 2010 Sep; 9(5):675-81. PubMed ID: 20553106
[TBL] [Abstract][Full Text] [Related]
5. Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases.
Emanueli A; Molari E; Pirola LC; Caputo G
Arzneimittelforschung; 1972 Nov; 22(11):1881-5. PubMed ID: 4267009
[No Abstract] [Full Text] [Related]
6. [Modern treatment of diabetes mellitus with sulfonylurea compounds].
Haller H; Hanefeld M; Leonhardt W
Z Arztl Fortbild (Jena); 1979 May; 73(10):482-7. PubMed ID: 158261
[No Abstract] [Full Text] [Related]
7. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.
Francis M; Langhan T; Prosser J; Hoffman R
Ann Emerg Med; 2008 Jun; 51(6):795-6; author reply 796-7. PubMed ID: 18489980
[No Abstract] [Full Text] [Related]
8. The E23K variant of KCNJ11 and the risk for severe sulfonylurea-induced hypoglycemia in patients with type 2 diabetes.
Holstein A; Hahn M; Stumvoll M; Kovacs P
Horm Metab Res; 2009 May; 41(5):387-90. PubMed ID: 19214942
[TBL] [Abstract][Full Text] [Related]
9. Long-acting sulfonylureas -- long-acting hypoglycaemia.
Veitch PC; Clifton-Bligh RJ
Med J Aust; 2004 Jan; 180(2):84-5. PubMed ID: 14723592
[No Abstract] [Full Text] [Related]
10. [The relatively frequent incidence of severe sulfonylurea-induced hypoglycemia in the last 25 years in Switzerland. Results of 2 surveys in Switzerland in 1969 and 1984].
Berger W; Caduff F; Pasquel M; Rump A
Schweiz Med Wochenschr; 1986 Feb; 116(5):145-51. PubMed ID: 3961464
[TBL] [Abstract][Full Text] [Related]
11. [88 severe incidents of hypoglycemia in patients under treatment with sulfonylurea compounds. Results of a survey throughout Switzerland during 1968 and 1969].
Berger W
Schweiz Med Wochenschr; 1971 Jul; 101(28):1013-22. PubMed ID: 5141777
[No Abstract] [Full Text] [Related]
12. [Incidence and severity of treatment-induced hypoglycemias in diabetics].
Hasslacher C; Wahl P
Dtsch Med Wochenschr; 1971 Nov; 96(46):1787-91. PubMed ID: 5000535
[No Abstract] [Full Text] [Related]
13. [Incidence of severe secondary effects during treatment with sulfonylureas and biguanides].
Berger W
Journ Annu Diabetol Hotel Dieu; 1986; ():243-53. PubMed ID: 3613372
[No Abstract] [Full Text] [Related]
14. Clinical comparison between glibornuride (Glutril) and tolbutamide in maturity-onset diabetes: a controlled double-blind trial.
Lindbjerg IF; Christoffersen EM; Kuusisto A; Lodahl K; Sagild U; Sterling N; Mikkelsen BO
Curr Ther Res Clin Exp; 1976 Sep; 20(3):277-82. PubMed ID: 134878
[No Abstract] [Full Text] [Related]
15. [Hardly any hypoglycemias, constant weight--and still cost effective].
MMW Fortschr Med; 2005 Nov; 147(47):72-3. PubMed ID: 16370200
[No Abstract] [Full Text] [Related]
16. Octreotide for hypoglycemia caused by sulfonylurea and DPP-4 inhibitor.
Yamaguchi S; Ikejima M; Furukawa A; Abe M; Nakazaki M; Ishihara H
Diabetes Res Clin Pract; 2015 Aug; 109(2):e8-e10. PubMed ID: 26025695
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic value of determining the hydroxy metabolite of glimepiride (M1) in blood serum in cases of severe hypoglycaemia associated with glimepiride therapy.
Holstein A; Plaschke A; Ptak M; Egberts EH; Tenberken O; Maurer HH
Diabetes Obes Metab; 2004 Sep; 6(5):391-3. PubMed ID: 15287933
[No Abstract] [Full Text] [Related]
18. [Differential therapy using oral antidiabetics].
Mehnert H
Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
[No Abstract] [Full Text] [Related]
19. A clinical evaluation of glibenclamide (HB 419, "Daonil") a new antidiabetic sulphonylurea.
Cheah JS
Singapore Med J; 1972 Apr; 13(2):87-90. PubMed ID: 4625992
[No Abstract] [Full Text] [Related]
20. Glipizide versus tolbutamide in maturity-onset diabetes, an open comparative study.
Fuchs K
Diabetologia; 1973 Sep; ():351-5. PubMed ID: 4772980
[No Abstract] [Full Text] [Related]
[Next] [New Search]
